Ryan Mee, CEO of Fulcrum Metals, reviews FY23 and progress on the Gold Tailings Hub in Canada. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEssensys Regulatory News (ESYS)

Share Price Information for Essensys (ESYS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 13.50
Bid: 13.00
Ask: 14.00
Change: 0.50 (3.85%)
Spread: 1.00 (7.692%)
Open: 13.50
High: 14.00
Low: 13.50
Prev. Close: 13.00
ESYS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Issue of Equity and Total Voting Rights

6 Sep 2023 07:00

RNS Number : 4689L
essensys PLC
06 September 2023
 

6 September 2023

 

essensys plc

("ESYS" or the "Company")

 

Issue of Equity and Total Voting Rights

 

essensys plc (AIM: ESYS), the leading global provider of mission critical software-as-a-service (SaaS) and technology platforms to the flexible workspace and commercial real estate industries, confirms that, following an exercise of options by former employees, it has issued and allotted 12,754 new ordinary shares of 0.25 pence each ("Ordinary Shares").

Application has been made to the London Stock Exchange for 12,754 new Ordinary Shares to be admitted to trading on AIM. Admission and dealings in the new Ordinary Shares is expected to occur at 8.00 a.m. on 11 September 2023.

The new Ordinary Shares will rank pari passu with the existing Ordinary Shares.

Total Voting Rights

Following Admission, the Company's total issued share capital will consist of 64,662,015 Ordinary Shares with one voting right per share. The Company does not hold any Ordinary Shares in treasury. Accordingly, the total number of voting rights in the Company is 64,662,015.

The above figure of 64,662,015 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company under the FCA's Disclosure Guidance and Transparency Rules.

For further information, please contact:

essensys plc

 

+44 (0)20 3102 5252

Mark Furness, Chief Executive Officer

 

 

Sarah Harvey, Chief Financial Officer

 

 

 

 

Singer Capital Markets (Nominated Adviser and Broker)

 

+44 (0)20 7496 3000

Peter Steel / Harry Gooden / James Fischer

 

 

 

 

FTI Consulting

 

 

Jamie Ricketts / Eve Kirmatzis / Talia Shirion / Victoria Caton

 

+44 (0)20 3727 1000

 

About essensys plc

essensys is the leading global provider of software and technology for flexible, digitally-enabled spaces, buildings and portfolios. The essensys Platform simplifies and automates the delivery and management of next generation, flexible, multi-tenant real estate.

The real estate industry is transforming - it must be flexible to changing market demands, accommodate hybrid working styles, provide move-in ready spaces and deliver frictionless experiences and on-demand services. The office sector is becoming an increasingly digital-first landscape - driven by end-user demand and delivering digitally enabled spaces is key to success. Our software and technology is designed and developed to help solve the complex operational challenges faced by landlords and flexible workspace operators as they grow and scale their operations. We help our customers to deliver a simple, secure and scalable proposition, respond to changing occupier demands in a hybrid world, provide seamless occupier experiences, and realise smart building and ESG ambitions.

Founded in 2006 and listed on the AIM market of the London Stock Exchange since 2019, essensys is active in the UK, Europe, North America and APAC.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IOEUVRNROBUKRAR
Date   Source Headline
30th Apr 20247:00 amRNSHalf year results
19th Apr 20249:00 amRNSNotice of Results
11th Jan 20247:00 amRNSBoard Change
7th Dec 202310:39 amRNSResult of AGM
23rd Nov 20237:00 amRNSIssue of Equity and Total Voting Rights
8th Nov 20237:00 amRNSPosting of 2023 Annual Report and Notice of AGM
31st Oct 20237:00 amRNSFull year results
23rd Oct 20237:00 amRNSInvestor Presentation via Investor Meet Company
19th Oct 20237:00 amRNSNotice of Results
6th Sep 20237:00 amRNSIssue of Equity and Total Voting Rights
31st Aug 20237:00 amRNSFull year trading update
4th Jul 20237:00 amRNSIssue of Equity and Total Voting Rights
28th Mar 20237:00 amRNSHalf year results
22nd Mar 202311:30 amRNSNotice of Results and Investor Presentation
28th Feb 20237:00 amRNSHalf Year Trading Update
6th Dec 20229:37 amRNSHolding(s) in Company
1st Dec 202212:04 pmRNSResult of AGM
1st Dec 20227:00 amRNSAGM Trading Update
7th Nov 20224:00 pmRNSPosting of 2022 Annual Report and Notice of AGM
1st Nov 20227:00 amRNSPublication of Audited Annual Report and Accounts
18th Oct 20227:00 amRNSFULL YEAR RESULTS
14th Oct 20227:00 amRNSNotice of Investor Presentation
26th Sep 20229:30 amRNSNotice of Results
16th Sep 202210:27 amRNSDirector/PDMR Shareholding
24th Aug 20227:00 amRNSFull Year Trading Update
17th May 20227:00 amRNSBoard Changes
9th May 20229:52 amRNSHolding(s) in Company
3rd May 20223:18 pmRNSDirector/PDMR Shareholding
26th Apr 20227:00 amRNSDirector/PDMR Shareholding
22nd Apr 20224:35 pmRNSPrice Monitoring Extension
22nd Apr 202211:05 amRNSSecond Price Monitoring Extn
22nd Apr 202211:00 amRNSPrice Monitoring Extension
21st Apr 202211:00 amRNSPrice Monitoring Extension
21st Apr 20229:05 amRNSSecond Price Monitoring Extn
21st Apr 20229:00 amRNSPrice Monitoring Extension
21st Apr 20227:00 amRNSHalf-year Report
29th Mar 20227:00 amRNSNotice of Investor Meet Company Presentation
22nd Mar 202210:46 amRNSHolding(s) in Company
18th Mar 20227:00 amRNSDirector/PDMR Shareholding
18th Mar 20227:00 amRNSDirector/PDMR Shareholding
17th Mar 20225:56 pmRNSDirector/PDMR Shareholding
11th Mar 202210:08 amRNSNotice of Results
10th Mar 202212:31 pmRNSHolding(s) in Company
2nd Mar 20224:41 pmRNSSecond Price Monitoring Extn
2nd Mar 20224:35 pmRNSPrice Monitoring Extension
1st Mar 20227:00 amRNSTrading Update
7th Feb 20227:00 amRNSAppointment of CEO UK & Europe and PDMR Dealing
3rd Feb 20227:00 amRNSBoard Changes
2nd Dec 202111:20 amRNSResult of AGM
16th Nov 20212:46 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.